Connect with us

Health & Fitness

BioNTech/Pfizer say vaccine can stand warmer temperatures

Germany’s BioNTech and its US partner Pfizer on Friday said tests have shown that their coronavirus vaccine can stand warmer temperatures than initially thought, potentially simplifying the jab’s complex cold-chain logistics.

Published

on

BioNTech/Pfizer say vaccine can stand warmer temperatures